BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19506299)

  • 1. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members.
    van Halteren AG; Jankowska-Gan E; Joosten A; Blokland E; Pool J; Brand A; Burlingham WJ; Goulmy E
    Blood; 2009 Sep; 114(11):2263-72. PubMed ID: 19506299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens.
    Burlingham WJ; Goulmy E
    Hum Immunol; 2008 Nov; 69(11):728-31. PubMed ID: 18812197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.
    Nakamura R; La Rosa C; Tsai W; Lacey SF; Srivastava T; Seidel A; Senitzer D; Forman SJ; Diamond DJ
    Transpl Immunol; 2014 May; 30(4):128-35. PubMed ID: 24582729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
    Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
    J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.
    Bleakley M; Otterud BE; Richardt JL; Mollerup AD; Hudecek M; Nishida T; Chaney CN; Warren EH; Leppert MF; Riddell SR
    Blood; 2010 Jun; 115(23):4923-33. PubMed ID: 20203263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans.
    James E; Chai JG; Dewchand H; Macchiarulo E; Dazzi F; Simpson E
    Blood; 2003 Jul; 102(1):388-93. PubMed ID: 12649154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HY immune tolerance is common in women without male offspring.
    Dierselhuis MP; Jankowska-Gan E; Blokland E; Pool J; Burlingham WJ; van Halteren AG; Goulmy E
    PLoS One; 2014; 9(3):e91274. PubMed ID: 24646895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.
    Mommaas B; Stegehuis-Kamp JA; van Halteren AG; Kester M; Enczmann J; Wernet P; Kögler G; Mutis T; Brand A; Goulmy E
    Blood; 2005 Feb; 105(4):1823-7. PubMed ID: 15498856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
    Warren EH; Greenberg PD; Riddell SR
    Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.
    Vacchio MS; Hodes RJ
    J Immunol; 2005 Apr; 174(8):4657-61. PubMed ID: 15814689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
    Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
    J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation.
    Spierings E; Vermeulen CJ; Vogt MH; Doerner LE; Falkenburg JH; Mutis T; Goulmy E
    Lancet; 2003 Aug; 362(9384):610-5. PubMed ID: 12944060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.
    Weng L; Dyson J; Dazzi F
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8415-20. PubMed ID: 17494756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
    Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+ CD25+ T-cell-dependent mechanism.
    Matsuoka K; Ichinohe T; Hashimoto D; Asakura S; Tanimoto M; Teshima T
    Blood; 2006 Jan; 107(1):404-9. PubMed ID: 16150938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent allorecognition has a limited impact on posttransplant vaccination.
    Manzo T; Hess Michelini R; Basso V; Ricupito A; Chai JG; Simpson E; Bellone M; Mondino A
    J Immunol; 2011 Feb; 186(3):1361-8. PubMed ID: 21209285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model.
    Araki M; Hirayama M; Azuma E; Kumamoto T; Iwamoto S; Toyoda H; Ito M; Amano K; Komada Y
    J Immunol; 2010 Dec; 185(12):7739-45. PubMed ID: 21078914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Dec; 178(2):974-81. PubMed ID: 22819314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of H-Y alloimmunity.
    Popli R; Sahaf B; Nakasone H; Lee JY; Miklos DB
    Immunol Res; 2014 May; 58(2-3):249-58. PubMed ID: 24781195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.